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Purpose: Autosomal dominant early-onset long anterior zonules (LAZs) and late-onset retinal degeneration (L-ORD) in
humans are associated with the S163R mutation of the complement 1q-tumor necrosis factor related protein-5 (CTRP5)
gene. For using the pig as an L-ORD model for the study of pathology, we cloned, characterized, and studied the expression
profile of pig CTRP5 (pCTRP5).
Methods: The pCTRP5 was cloned and sequenced from porcine genomic DNA. Bioinformatic analysis was done to
evaluate the functional domains present in the pCTRP5 using PROSITE tools. The V5 epitope-tagged constructs of
pCTRP5 and the mammalian promoters, elongation factor 1-α (EF) promoter and 579 bp of the putative promoter located
upstream to pCTRP5 DNA, were used for in vitro expression analysis. The pCTRP5 expression, protein size, and cellular
localization were studied in transiently transfected Cos-7 or ARPE-19 cells by western blot analysis using anti-CTRP5
and anti-V5 epitope antibodies. Expression of pCTRP5 in the pig eye tissues was analyzed by western blot analysis, real-
time PCR, and immunohistochemistry.
Results: As predicted, pCTRP5 showed a 92% DNA homology and 98% amino acid homology with human CTRP5
(hCTRP5). Bioinformatic analysis revealed the presence of an alternate in-frame translational start site upstream to the
presumed initiator codon. The presence of a putative promoter region upstream to the pCTRP5 was identified. The putative
pCTRP5 promoter was found to be functional by western blot analysis. The size of the pCTRP5 protein (pCTRP5) was
consistent with its predicted molecular weight, indicating that the potential alternative start site was not used. Western
blot and RT–PCR analyses showed that pCTRP5 was predominantly expressed in RPE, a pattern of expression consistent
with that found in mouse and human eyes.
Conclusions: The sequence and genomic organization of pCTRP5 was found to be similar to the human homolog. The
DNA and protein sequence of pCTRP5 are highly homologous to hCTRP5, indicating that they are highly conserved. A
putative promoter region (579 bp) present upstream to pCTRP5 was found to be functional and was able to drive the
expression of the pCTRP5 gene cloned downstream. The tissue distribution in the eye and the expression profile of pCTRP5
in transiently transfected cells is consistent with hCTRP5 expression. Immunohistochemistry analysis of the pig retinal
sections revealed localization of pCTRP5 to the apical and basolateral regions on the RPE and in the ciliary body. The
potential in-frame alternate start site was found to be nonfunctional by western blot analysis of transiently transfected
cells. Similarities between human and pig CTRP5 and the presence of an area centralis region in the pig similar to the
human macula, together with its large eyeball size, makes the domestic pig a good model for the study of LAZs and L-
ORD.
Late onset retinal macular degeneration (L-ORD) is an
autosomal dominant retinal degeneration that is characterized
by  bilateral  vision  loss,  dark-adaptation  abnormalities,
drusenoid  deposits,  lens  anterior  zonules,  retinal
degeneration,  and  choroidal  neovascularization  in  humans
[1-3].  Patients  with  L-ORD  often  present  symptoms
indistinguishable  from  early-stage  age-related  macular
degeneration (AMD) or from retinal degeneration (RD) in its
later stages. However, anterior segment abnormalities with
Correspondence  to:  Robert  M.  Petters,  Department  of  Animal
Science,  North  Carolina  State  University,  Campus  Box  7621,
Raleigh, NC, 27695; Phone: (919) 515-4021; FAX: (919) 515-6884;
email: bob_petters@ncsu.edu
long anterior zonules (LAZs) are seen only in L-ORD patients
and are not observed in AMD or RD. L-ORD is known to be
caused by a single missense mutation, S163R, in a conserved
domain of the C1q tumor necrosis factor-related protein 5
gene  (CTRP5)  [3].  Patients  with  the  S163R  heterozygous
mutation  showed  abnormal  lens  zonules  (in  the  second
decade), dark adaptation abnormalities in the fourth decade,
progressing  to  drusen  and  macular  degeneration  with
choroidal  neovascularization  (fifth  decade).  Some  of  the
patients developed iris atrophy and secondary glaucoma in
their 60s [3-5].
CTRP5 is a short chain collagen gene that encodes a
25 kDa secretory glycoprotein with three conserved domains:
a signal peptide (residues 1–15), a collagen domain (residues
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9230–98) containing 23 uninterrupted gly-X-Y repeats, and a
C1q domain (residues 99–243). It is highly expressed in the
RPE and ciliary epithelial layers in the eye [6]. Expression of
CTRP5 is also reported in serum, adipocytes, and other tissues
in the body [7,8]. The protein and DNA sequence of CTRP5
is highly conserved in mammals, birds, and zebra fish [9].
CTRP5 is known to express as a dicistronic transcript and is
located in the 3′ untranslated region of the membrane-type
frizzled-related  protein  (MFRP)  gene  [10].  A  functional
promoter for human CTRP5 (hCTRP5) has been identified in
its 5′ region [11].
The  CTRP5  protein  has  been  shown  to  interact  with
complement factor H (CFH), which has been reported to be a
major genetic factor associated with AMD and an early-onset
recessive drusen phenotype (Figure 1) [12]. Apart from CFH,
CTRP5  is  also  known  to  interact  with  membrane-type
frizzled-related  protein  (MFRP)  [13].  The  C1q  domain
present  in  CTRP5  is  known  to  strongly  interact  with  the
complement C1r/C1s, Uegf, Bmp1 (CUB) domains joined by
LDLa  (together  known  as  the  CUBT  domain)  in  MFRP.
Mutations  in  MFRP  are  reported  to  cause  an  autosomal
recessive syndrome of nanophthalmos, retinitis pigmentosa,
foveoschisis, and optic disc drusen in human subjects and
retinal degeneration in the rd6 mouse model [10,14]. The
highest levels of CTRP5 and MFRP expression were detected
in RPE and the ciliary body, the tissues that are involved in
the disease pathology [3]. Even though CTRP5 is known to
interact  with  CFH  and  MFRP,  its  function  in  disease
pathology is not known to date.
There  are  many  currently  existing  mouse  models  for
studying AMD that mimic most of the phenotypic features
present in humans [15]. However, the greatest phenotypic
difference between humans and mice relates to ocular size. In
addition, to understand the mechanism underlying L-ORD or
AMD, studying an animal model having a foveal pit or macula
is justified, rather than studying mouse models, since mice
lack both these features. Since the pig has a distinct macula-
like region, the area centralis, with a high concentration of
cones [16-18], it will be a better model for studying macular
degeneration. Understanding the structure and expression of
CTRP5 in the pig will enable us to manipulate it and to make
models to mimic the disease in human L-ORD patients. In the
present  study,  we  describe  the  cloning,  sequencing,  and
characterization of CTRP5 in pigs (pCTRP5, in Sus scrofa)
and  its  putative  promoter.  These  studies  will  provide  the
background for the development of a pig model of LAZs and
L-ORD for the investigation of therapeutic interventions.
METHODS
All animal protocols were conducted in accordance with state
and federal guidelines and were approved by the Institutional
Animal  Care  and  Use  Committee,  North  Carolina  State
University.
Cloning pCTRP5 and constructing the expression vector:
PCR primers, CTRP5 6up (5′-GCG ACA CCA CGA GTT
ATT TCC CTG-3′) and 2082lp (5′-AGC CCT CCC TTC TGC
CTG  AAC  AC-3′),  were  used  to  amplify  2,146  bp  of
CTRP5 from the pig genomic DNA using Phusion Hot Start
High-fidelity  DNA  polymerase  (New  England  BioLabs,
Ipswich, MA). The PCR amplicon was agarose gel purified
and annealed with “A” overhangs before cloning into the
mammalian  expression  vector  pEF6/V5-His-TOPO
(Invitrogen, Carlsbad, CA). The positive clones containing
pCTRP5  were  confirmed  by  PCR  amplification  using  the
nested primer set CTRP up/lp (5′-CCT TCG ACC GCG TGC
TG-3′ and 5′-AGC AGA GGC TGG CTT GGG C-3′), which
flanks the Ser163 codon in exon 2 of pCTRP5. This vector
was  called  pEF  CTRP5  wt.  An  Arg163  mutation  was
introduced by site-directed mutagenesis into the pEF CTRP5
wt plasmid using the 5′ phosphorylated primers CTRP5 AGG
mut F (5′[P]-CTC TTG GAG TCT GGG AGG AGC A-3′)
and CTRP5 AGG mut R (5′[P]-CTG GTC AAG AAT GGC
GAG TCC AT-3′) for amplification and then recircularization
to make the pEF CTRP5 mt plasmid. Restriction endonuclease
digestion  analysis  with  NheI  was  used  to  screen  for  the
mutation because the C→G mutation eliminates the NheI site.
Positive clones containing the mutant CTRP5 were confirmed
by sequencing. A possible promoter and alternative in-frame
ATG start site found in the 5′ upstream sequence of the pig
Figure  1.  Western  blot  indicating  an
interaction between CTRP5 and CFH.
The blot was probed with an hCTRP5
protein  antibody.  Lane  A,  with
molecular  weight  markers  from  the
same blot, is presented adjacent to lanes
B-D:  lane  B  is  purified  V5  tagged
hCTRP5  protein;  lane  C  is  the
immunoprecipitated (IP) fraction with
the IgG control antibody and the western
blot with the hCTRP5 antibody; lane D
is the IP fraction with 1.5 μg human
complement  factor  H  antibody  and
western blot with hCTRP5 antibody.
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93genomic DNA was removed from with the 5′ phosphorylated
primer set: ATG out up (5′[P]-GAG GCC GGG AGC GAG
GCT TGT C-3′) and ATG out lp (5′ [P]-ACT GGT GTC GCA
AGG  GCA  ATT  C-3).  The  resulting  amplicon  was
recircularized. We called this version of the CTRP5 “S” for
short (pEF CTRP5 S).
For ease of detection of protein expression in transient
transfection assays, a 3′ in-frame fusion was made with the
V5 epitope of the pEF6/V5-His-TOPO cloning vector. The
abbreviation “T” (for “tagged”) was used to denote plasmids
that were V5 epitope-tagged (e.g., pEF CTRP5 wt T). To
investigate  the  promoter  activity  of  the  CTRP5  upstream
sequence, we made constructs with EF promoter and putative
pCTRP5 promoter sequences cloned upstream to pCTRP5.
These constructs were transiently transfected into ARPE-19
cells or Cos-7 cells to study the pCTRP5 (protein) expression
by western blot and immunocytochemistry analysis.
5′  RACE  analysis  of  pCTRP5:  To  determine  the
transcription start site of pCTRP5, a 5′ RACE was performed
using the RNA isolated from pig RPE tissue using an RNeasy
Mini isolation kit (Qiagen, Valencia, CA). Ten micrograms
of the total RNA was used with the First Choice RLM RACE
kit  (Invitrogen).  The  cDNA  was  synthesized  using  an
Enhanced Avian RT first-strand synthesis kit (Sigma-Aldrich,
St. Louis, MO) at 65 °C using a primer specific to the CTRP5
coding sequence (Primer Race1: 5′-CCC TCG CCT TTC TCT
CCC-3′). PCR was performed with NEB’s Long Amp DNA
polymerase using these primers: 5′ RACE Outer Primer (5′-
GCT GAT GGC GAT GAA TGA ACA CTG-3′) and reverse
Race2 (5′- GCC TTT CTC TCC CGG AGC-3′). A nested PCR
reaction using the same conditions and the following primers
was performed: 5′ RACE Inner Primer (5′-CGC GGA TCC
GAA CAC TGC GTT TGC TGG CTT TGA TG-3′) and
reverse Race6 (5′-GCG TGC CAG GAA GGC CGG-3′). The
amplification product was gel-purified and sequenced with
the reverse Race6 primer.
Bioinformatic analysis and prediction of a core promoter
region for pCTRP5: A bioinformatic search was done with
pCTRP5 DNA and protein sequences using NCBI-BLAST to
check  for  homology  with  other  DNA  and  proteins  in  the
database.  ClustalW  software  was  used  to  determine  the
percentage of homology of pCTRP5 with its orthologs for both
DNA and protein. The presence of functional protein domains
was tested using PROSITE tools. We used both PROSCAN
Ver. 1.7 and TSSG server software to determine the presence
of a putative promoter and of transcriptional start sites in the
5′ region of the pCTRP5 sequence [19]. We also screened the
5′ sequence upstream to pCTRP5 for the presence of CpG
islands using CpG islands searcher software [20].
Transfection of Cos-7 and ARPE-19 cells: Cells were
transiently transfected with the expression constructs using
Lipofectamine  2000  reagent  (Invitrogen)  according  to  the
manufacturer’s instructions [21]. Four hours after transfection
was initiated, the transfection mix was replaced with serum-
containing medium and incubated for another 48 h before
experiments  were  performed.  Mock  transfections  were
performed using Lipofectamine 2000 only [21].
Analysis of wild-type and mutant pig CTRP5 expressed
in Cos-7 cells: Cos-7 cells were transfected with the wild type
(pCTRP5  wt  T)  and  mutant  (pCTRP5  mt  T)  expression
constructs according to previously published protocols [21].
The  expression  of  hCTRP5  under  the  control  of
cytomegalovirus (CMV) promoter [6] was used as a positive
control. The cells were harvested after 48 h posttransfection
to  prepare  lysates.  A  protease  inhibitor  cocktail  (Sigma
Aldrich) was added to the lysis buffer (50 mM Tris-HCl [pH
7.4], 0.15 M NaCl, 1 mM EDTA, 0.1% Triton X-100, and
0.1% [W/V] SDS). Western blot analyses were performed
with  30  µg  reduced  proteins  (by  adding  0.5%  β-
mercaptoethanol to the SDS sample buffer) separated on 10%
Bis-Tris gel (Invitrogen). After the western transfer, the blot
was probed with rabbit anti-CTRP5 antibody [6].
Quantitative  expression  of  pCTRP5  in  different  eye
tissues: Quantitative RT–PCR (qRT–PCR) and data analysis
were performed according to previously published protocols
[6]. Initial denaturation of the cDNA was done at 94 °C for 1
min for one cycle followed by 40 cycles of denaturation at
95 °C for 10 s, annealing at 56 °C for 30 s, and elongation at
72 °C for 40 s. Primers 5′-GTC CAT CGC CTC TTT CTT
CC-3′ (forward primer) and 5′-ATG CCA ATG TAG TCA
CCC AC-3′ (reverse primer) were used for amplification of
pCTRP5. The expression of pCTRP5 was determined in pig
eye tissues (cornea, ciliary body-iris [CB-I], lens, retina, and
RPE).  In  addition,  four  housekeeping  genes—Gapdh,
HPRT, β-actin (Actb), and RpL19—were also analyzed as
controls to normalize the expression of pCTRP5. Expression
levels (±standard error of the mean [SEM]) were calculated
by analyzing at least three independent samples with replicate
reactions and presented on an arbitrary scale that represented
its  expression  over  the  housekeeping  gene.  The  data  was
presented using the HPRT gene for normalization.
Immunohistochemistry:  For  immunolocalization  of
antigens, eyes from 7.4-month-old pigs were fixed in 4%
paraformaldehyde in 0.1 M phosphate buffer. Eyes in fixative
were thoroughly washed with 1X PBS, cryoprotected in 30%
sucrose, and embedded in OCT before sectioning. To localize
pCTRP5 in the eye tissue, immunohistochemistry (IHC) was
performed  using  anti-CTRP5  polyclonal  antibody,  as
described earlier [6,11]. Sections were mounted in mounting
medium containing DAPI, they were observed with a Zeiss
confocal microscope, and images were captured.
RESULTS
Characterization of pCTRP5: A 2146 bp fragment of pig
genomic DNA containing the presumed coding region for
CTRP5  (Figure  2A)  was  cloned  into  the  mammalian
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94expression vector pEF6/V5-His-TOPO (referred to as pEF
CTRP5 wt). Amplification with nested CTRP5-specific PCR
primers and subsequent sequencing confirmed the presence
of the pCTRP5 coding sequence (Figure 2A).
Sequencing analysis of the cloned pCTRP5 revealed it is
732 bp long with two exons that might encode for a 243 amino
acid protein (molecular weight [MW] was nearly 25.5 kDa).
DNA sequence’s homology with its human ortholog is 92%
and amino acid homology is 98%; with variations at only 5
amino acid residues (Figure 2B). The sequence comparisons
of pCTRP5 with other vertebrate and invertebrate sequences
showed a high conservation of the C1q domain, which is the
functionally  active  domain  of  CTRP5  [7,22].  PROSITE
analysis showed the presence of the collagen domain to be
from 36 to 95 amino acids and of the C1q domain to be from
105  to  232  amino  acids  in  pCTRP5  protein.  The  region
between 102 and 235 amino acids showed homology with the
tumor necrosis factor-like protein family of proteins. Analysis
of the genomic sequence indicated that a potential in-frame
alternative  start  codon  141  bp  upstream  of  the  predicted
pCTRP5 start codon, if translated, would result in an extra 47
amino  acids  at  the  N-terminus,  to  yield  a  protein  of  the
predicted size of nearly 31 kDa (Figure 2A).
The CpG island search software detected the presence of
a single CpG island of 578bp with a GC content >70.6%. The
observed CpG/expected CpG ratio in this region is greater
than 0.65. Presence of a CpG island in the putative promoter
region of pCTRP5 may help either to initiate DNA replication
or transcription.
Transient expression of CTRP5 in Cos-7 and ARPE-19 cells:
To test whether the cloned pCTRP5 was capable of expressing
pCTRP5, we cloned 2164 bp of pCTRP5 downstream to the
human elongation factor 1α (EF) promoter (pEF CTRP5 wt).
We used this vector to produce a series of expression vectors,
including V5 epitope “tagged” (T) CTRP5 and “short” (S)
versions that did not contain a 5′ upstream genomic sequence
that included a putative pCTRP5 promoter and a potential
alternative translational start site (pCTRP5 wt T and pCTRP5
wt S) expression vector. R163 mutant (mt) variations of each
plasmid were also produced to test for their expression (Figure
3). The resulting plasmids were transiently transfected into
Cos-7  cells  and  ARPE-19  cells  independently,  and  the
expression of pCTRP5 protein was studied using western blot
analysis.
Western blot analysis with Cos-7 cells transfected with
the plasmids pEF CTRP5 wt T and pEF CTRP5 mt T were
incubated  with  an  anti-V5  antibody  to  detect  the  CTRP5
fusion protein (Figure 4). The expression of the pCTRP5 V5
fusion  protein  indicated  the  functionality  of  the  cloned
pCTRP5 in producing CTRP5 (~31 kDa). The expression of
pCTRP5 was comparable to the levels of CTRP5 produced by
the V5 epitope-tagged hCTRP5 gene expressed under the
control of the CMV promoters (pCMV CTRP5 wt T and
pCMV CTRP5 mt T) that were used as controls.
Promoter  analysis  of  pCTRP5:  Promoter  identification
software detected a TATA-less putative promoter region of
an approximately 579 bp sequence upstream of the predicted
pCTRP5 initiation codon. The Proscan Version 1.7 software
tool predicted this promoter region to be in proper orientation
to the start site, with a promoter score of 53.45 (promoter
cutoff=53.0). The TSSG program, which searches for human
PolII  promoter  regions,  predicted  a  promoter  with  a
transcriptional  start  site  at  −245  bp  from  the  start  of
translation, with a linear discriminant factor (LDF) score of
7.59  (threshold  for  LDF=4.00).  Analysis  of  the  putative
pCTRP5  promoter  region  (579  bp)  also  identified  several
possible transcription-factor binding sites, including one site
of NF-kB and four sites for the Sp1 binding site within the
sequence (Table 1). The presence of a TATA box or GATA
box was not detected, indicating that the pCTRP5 promoter
might be a TATA-less promoter.
To test the functionality of the predicted promoter, the
putative promoter region (579 bp) was cloned upstream to the
start site of pCTRP5 and analyzed for its ability to express
pCTRP5. Immunocytochemistry analysis was done to analyze
protein  expression  in  ARPE-19  cells  transfected  with  the
pCTRP5  wt  T  and  pCTRP  mt  T  constructs.  The  579  bp
pCTRP5 promoter was capable of expressing pCTRP5, which
was  detected  using  anti-CTRP5  antibody  and  anti-V5  tag
antibodies  (data  not  shown).  Furthermore,  western  blot
analysis of Cos-7 transfected with pCTRP5 under the control
of the 579 bp pCTRP5 promoter demonstrated high levels of
expression of both the wild-type and mutant pCTRP5 proteins
(Figure 5). The above results confirmed the functionality of
the  putative  pig  promoter.  The  pEFα  promoter  driving
expression of pCTRP5 V5 fusion genes were used as controls.
Determination of the translational start site of pCTRP5: To
investigate  the  potential  translational  start  site  of  the
pCTRP5 gene, Cos7 cells were transfected with two different
expression constructs. These constructs contained either the
potential alternative in-frame start sites (pEF CTRP5 wt T and
pEF CTRP5 mt T) or truncated versions of the expression
vectors (pEF CTRP5 wt ST and pEF CTRP5 mt ST) that
lacked  the  potential  alternative  start  site  (Figure  6).  The
transfected Cos-7 cell lysates were analyzed using western
blot analysis with an anti-CTRP5 antibody and an anti-V5
epitope  antibody.  Detection  with  the  above  antibodies
revealed that transfected cells expressed pCTRP5 protein with
a molecular weight of 31 kDa. Translation from the in-frame
alternative start site would have resulted in the expression of
a 36 kDa protein. These results suggest that, even though a
potential in-frame ATG was present in exon 1, only the second
ATG was used for translation of CTRP5 (Figure 6).
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95Figure 2. Genomic structure of pCTRP5 and protein homology of pig CTRP5 with the human protein. A: The pCTRP5 was amplified from
genomic DNA by PCR, cloned, and sequenced. The pCTRP5 consists of two exons; its coding sequence is highlighted in yellow, the Ser163
codon is highlighted in red, a potential in-frame alternative start codon is highlighted in pink, the transcriptional start site (TSS) is highlighted
in blue, and various transcription factor binding sites are highlighted in green. B: The protein homology between the pCTRP5 and hCTRP5
protein is represented. The pCTRP5 protein sequence is shown in black and the human in blue. The underlined residues indicate the five amino
acid differences between the pig and human protein. The Ser shown in red indicates residue 163.
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96Determination of the pCTRP5 transcriptional start site: 5′
RACE was performed to determine the transcriptional start
site of the endogenous pCTRP5 gene. RNA purified from the
pig  retinal-pigmented  epithelium  was  used  as  the  starting
template  for  the  RACE  adaptor  ligation  and  reverse
transcription reaction. Sequencing of a PCR product from the
5′ RACE reaction determined that the transcriptional start site
was located at −65 bp from the initiation codon ATG (Figure
2A). The detected transcriptional start site (TSS) was found
to be downstream of a potential in-frame initiation codon (77
bp downstream to the alternate initiation codon), indicating
that it was not used for the generation of the 5′ RACE product.
Expression of pCTRP5 in various eye tissues and localization
in the eye: We examined pCTRP5 gene expression in different
pig  eye  tissues  using  quantitative  reverse  transcription
polymerase chain reaction (qRT–PCR) on cDNA produced
from total mRNA isolated from the retina, optic nerve, lens,
RPE, choroid, and ciliary body of a 222-day-old pig. The
highest level of pCTRP5 expression was detected in the RPE,
although pCTRP5 messages were expressed in the ciliary
body, optic nerve, and choroid. Minimal expression levels of
the pCTRP5 transcript were detected in the pig retina and lens
(Figure 7A).
Western blot analysis was performed using the protein
lysates  of  the  above  tissues.  The  pCTRP5  protein  was
primarily detected within the RPE (Figure 7B) as ~31 kDa
protein (Figure 7B) but not in other eye tissues, indicating that
the RPE was the predominant tissue expressing the CTRP5
protein. To localize the presence of CTRP5 protein in the pig
eye, IHC was performed with an anti-CTRP5 antibody. The
pCTRP5 protein was localized predominantly to the basal
RPE layers of the eye (Figure 7C). Staining of CTRP5 was
Figure  3.  Expression  constructs
designed  for  studying  expression  of
pCTRP5  and  pCTRP5  promoter
activity.  Six  constructs  were  made  to
investigate  pCTRP5  expression  and
putative pCTRP5 promoter activity. The
initial vector was pEF CTRP5 wt. All
other  vectors  were  based  on
modifications to this expression vector.
Figure  abbreviations  are  as  follows:
wt=wild type Ser163 allele, mt=Arg163
mutation,  T=V5  epitope  tagged,
S=pCTRP5  short.  The  short  pCTRP5
genomic fragment is missing 461 bp of
the  upstream  sequence,  including  the
possible  promoter  and  alternative  in-
frame start site. Constructs made with
EF1α  promoter  were  used  as
experimental  controls  for  promoter
expression studies.
Figure 4. Western blot of lysates of cells
transfected with pig CTRP5 and human
CTRP5  constructs.  Western  blot
analysis  was  performed  with  anti-V5
antibody  on  lysates  from  Cos-7  cells
transfected with pEF CTRP5 wt T (lane
2), pEF CTRP5 mt T (lane 3), pCMV
CTRP5 wt T (lane 4), pCMV CTRP5 mt
T  (lane  5),  and  nontransfected  Cos7
cells  (lane  1).  Lanes  4  and  5  were
transfected  with  hCTRP5  expression
vectors as a positive control. Detection
with anti-V5 antibody produced a single
band with a molecular weight around
31 kDa for both the pCTRP5 (lanes 2
and 3) and hCTRP5 (lanes 4 and 5) V5-
tagged protein.
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97also observed on the apical and lateral regions throughout the
retina (Figure 7C). From the above analysis it appears that,
although the pCTRP5 transcript was detected in various eye
tissues, it was predominantly expressed and localized to the
RPE layer in pig eye.
The  localization  pattern  of  pCTRP5  in  the  ciliary
epithelium (CE) of pigs was demonstrated by IHC using the
anti-CTRP5  antibody.  Immunofluorescence  microscopy
showed that pCTRP5 was localized to predominantly to the
apical and few basal membrane surfaces of the pigmented and
nonpigmented cells, and was abundantly present in the CE
layers (arrows in Figure 7D). Among the ciliary epithelial
layers, pCTRP5 was found to be significantly localized in the
outer layer between both layers, unlike the mouse CTRP5 that
was reported to be localized in the apposed apical membrane
surfaces of the CE layers [6]. The variation observed in the
localization pattern of CTRP5 between mouse, human, and
pig  retinal  sections  could  be  due  to  the  difference  in  the
specificity  of  anti-human/-mouse  CTRP5  polyclonal
antibodies  against  the  pig  protein.  Similar  to  the  pattern
observed in the mouse RPE cells, pCTRP5 also showed a
TABLE 1. LIST OF TRANSCRIPTION FACTORS BINDING SITES IDENTIFIED IN THE 579 BP UPSTREAM PROMOTER REGION OF THE PIG CTRP5 GENE.
Binding site Identification* Location from start of translation (bp)
Alpha INF S01153 (−378 to −373)
AP-2 S01936 (−470 to −463)
GCF S01964 (−54 to −48) (−169 to −163) (−271 to −265)
(−385 to −379) (−387 to −381)
H4TF-1 S01969 (−256 to −248) (−262 to −254) (−304 to −293)
H4TF-2 S00742 (−398 to −394)
JVC repeat sequences S01193 (−254 to −247) (−260 to −253) (−299 to −292) (−319 to −312) (−324 to
−317) (−500 to −493)
LBP-1 S02121, S00487 (−503 to −499) (−521 to −517)
Lf-A1 S00250 (−534 to −529)
NF-kB S01498 (−208 to −200)
SDR S01561 (−335 to −328)
Sp1 S00781, S00978 S00857,
S00979
(−321 to −313)
T-Ag S00973, S00974 S02135,
S01375
(−192 to −188) (−277 to −273) (−320 to −316) (−374 to −370) (−443 to
−439) (−458 to −454)
TCF-1 S02023 (−379 to −375)
UCE.2 S00437 (−165 to −161) (−105 to −101)
v-Myb S01896 (−523 to −518)
        Selected transcription factor binding sites were identified using Proscan V1.7 and TSSG searches. *Motif identificators from
        the Ghosh database.
Figure 5. Western blot analysis of Cos-7
cells lysates transfected with pig CTRP5
promoter  constructs.  A:  Cos-7  cells
were transfected with pEF-CTRP5 wt
ST (lane 1), pEF-CTRP5 mt ST (lane 2),
pCTRP5 wt T (lane 3), and pCTRP5 mt
T  (lane  4)  and  the  cell  lysates  were
incubated with anti-V5 antibody. B: The
membrane was stripped and incubated
with anti-CTRP5 polyclonal antibody.
A  single  protein  with  as  size  of
approximately  31  kDa  was  identified
using either antibodies indicating the V5
tagged  CTRP5  protein  is  being
expressed  (A  and  B).  The  putative
pCTRP5  promoter  is  capable  of
expressing  the  V5  tagged  protein
confirming  the  functionality  of  the
pCTRP5 promoter (A lanes 3 and 4; B
lanes 3 and 4).
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98predominantly punctate distribution in the ciliary epithelium
[6].
DISCUSSION
The Ser163Arg mutation in hCTRP5 is known to cause the
autosomal dominant pathology associated with early-onset
LAZs and late-onset retinal degeneration [3,9]. Developing
suitable animal models that mimic the human phenotype is
critical to understanding the disease pathology caused by gene
mutations. The phenotype of these patients resembles that of
patients with AMD and RD. There are multiple mouse models
showing  pathological  features  mimicking  those  of  AMD
[15]. In spite of having many phenotypic similarities with
AMD patients, the mouse eye differs significantly from the
human  eye,  due  to  the  mouse  eye’s  smaller  size  and  the
absence of a cone-rich region, the macula. A pig model can
serve as an alternative best model to study AMD due to the
presence of the cone-rich region, called the area centralis, and
its bigger eye size compared to that of the mouse. To generate
a pig model for L-ORD in future, we cloned and characterized
the genomic pCTRP5 gene. This is the first study describing
pCTRP5 and its expression and localization pattern in the pig
eye. This study also confirmed the presence of an independent
promoter for pCTRP5 that is similar to but smaller than the
human promoter [11].
To  characterize  pCTRP5,  we  cloned  the  gene  from
genomic DNA and sequenced it. The first release (April 2009)
of the high-coverage Sus scrofa assembly for chromosomes 1
to 18 and X of the pig genome is available through Ensembl
browser [23]. We compared the pCTRP5 gene sequence we
generated with the public domain sequence and found a 100%
match  between  the  two  sequences.  Initally,  the  hCTRP5
transcript was found to be present in the 3′ untranslated region
of  the  full  length  hMFRP  transcript  [6].  We  have  since
identified  an  autonomous  hCTRP5  promoter  [11].  The
genomic organization between the coding exons in pCTRP5
(exon 1 and exon 2) and hCTRP5 (exon 1 and exon 2) is very
similar. They both have the same-size exons of 215 bp and
517 bp for, respectively, the first and second coding exons.
The gene sequence homology of both the DNA and protein
was compared with other ortholog sequences. The DNA and
protein alignments of the pCTRP5 gene showed, respectively,
a 92% DNA homology and a 98% amino acid homology with
hCTRP5. ClustalW sequence analysis of the 579 bp sequence
upstream to the CTRP5 gene in pigs and humans revealed an
alignment score of 74%, indicating that they are conserved.
The CTRP5 message is reported to be expressed as two
isoforms in humans: a dicistronic transcript of CTRP5 with
the MFRP gene in its 5′ region, and a monocistronic transcript
without MFRP [24]. The CUB domains present in human
MFRP interact with the C1q domain in CTRP5, suggesting
Figure 6. Western blot analysis for the
detection of functional ATG start site for
pCTRP5.  A:  western  blot  analysis  of
Cos-7 cell lysates transfected with pEF-
CTRP5 wt T (lane 2), pEF CTRP5 mt T
(lane 3), pEF CTRP5 wt ST (lane 4),
pEF  CTRP5  mt  ST  (lane  5),  and
nontransfected  Cos-7  cells  (lane  1)
incubated with anti-CTRP5 polyclonal
antibody. B: The blot was stripped and
incubated  with  anti-V5  antibody.  A
single  31  kDa  protein  was  detected
using either antibody. This indicates that
only the predicted ATG is the functional
for the translation of CTRP5 (A and B).
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99Figure 7. Expression and localization of CTRP5 in the pig eye. A: Expression of pCTRP5 was studied by qRT–PCR using total mRNA extracted
from different tissues of a 222-day-old pig eye. The pCTRP5 expression is presented as bars using an arbitrary scale on the y axis. Values are
presented as mean (±SEM) of three independent observations after normalization with the control gene (HGPRT) B: western blot analysis of
CTRP5 protein extracted from a 222 days pig. Retina (lane 1), optic nerve (lane 2), lens (lane 3), RPE (lane 4), ciliary body (lane 5), Choroid
(lane 6). Detection with an anti-CTRP5 antibody shows significant expression of pCTRP5 protein in the RPE with an expected size molecular
weight of approximately 31 kDa. C: Localization of CTRP5 in retinal sections as evaluated by IHC analysis of retinal sections with human
monoclonal anti-CTRP5 antibody and Alexa Fluor 488 staining (green, arrows), nuclei (*) stained with DAPI (blue). D: Localization of CTRP5
in the ciliary body as shown by IHC with human monoclonal anti-CTRP5 antibody and Alexa Fluor 555 (red, arrows), nuclei stained with
DAPI (blue).
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dicistronic  genes  [13,25,26].  The  MFRP  gene  in  pigs  is
reported to be around 1,707 bp, encoding a putative protein of
508 amino acids, as found in the Ensembl browser [23]. Like
human MFRP, pig MFRP also has 13 exons. Domain analysis
of  the  pMFRP  gene  showed  that  it  consists  of  two  CUB
domains (CUB1: 132 to 238 bp; CUB2: 289 to 403 bp), Ldla
domain (244–287 bp) and a Frizzled domain (Fz: 454 to −563
bp).  Unlike  the  human  gene,  only  the  monocistronic
transcripts are reported for the pig MFRP and CTRP5 genes
in  the  Ensembl  browser,  suggesting  that  the  bicistronic
MFRP-CTRP5 transcripts may be absent in pigs.
Analysis of the pCTRP5 DNA sequence noted a potential
in-frame  alternate  start  site  upstream  from  the  presumed
coding sequence. Western blot expression analysis indicated
that this potential in-frame start site was not translated (Figure
6). The 5′ RACE analysis of expressed pCTRP5 mRNA from
the RPE indicated that the TSS was located −65 bp to the
presumed initiation codon and +77 bp from the potential in-
frame alternate start site (Figure 2A). The TSS (−65 bp) of
pCTRP5 was similar in distance from the initiation codon, as
we previously found with the independent hCTRP5 promoter
(TSS −62 bp) [11]. Finally, the size of the pCTRP5 protein
found in the pig eye was consistent with the predicted size
(Figure 6B). Combined, these observations indicate that the
cloned genomic pCTRP is expressed properly in vitro.
Apart  from  characterizing  pCTRP5  and  pCTRP5,
sequence analysis revealed the presence of an autonomous
promoter for pCTRP5. We recently described an autonomous
promoter  function  for  hCTRP5;  the  results  of  the  present
finding are consistent with that report [11]. The sequences to
the ATG start site in both human and pig CTRP5 genes are
highly conserved, with 73% homology. The cloned promoter
region was capable of expression in both Cos-7 (Figure 5)
cells  and  ARPE-19  cells  (data  not  shown),  indicating  the
functionality  of  the  predicted  promoter  region.  Further
characterization of this promoter is necessary to determine the
core promoter region.
CpG islands (CGIs) are clusters of CpG dinucleotides in
GC-rich regions. They are also defined as regions with at least
200 bp, with a GC percentage that is greater than 50% and
with an observed/expected CpG ratio that is greater than 60%
[27].  In  humans  and  mice,  approximately  60%  of  all
promoters  colocalize  with  CpG  islands  [28].  Similar  to
hCTRP5,  the  CpG  island  search  software  predicted  the
presence of a CpG island in the 5′ region of the pCTRP5
sequence. A single CpG island of 578 bp with a GC of less
than 70.6% and an observed to expected CpG ratio of 0.66
was identified in pCTRP5, which may be involved in the
initiation of DNA replication or transcription. The presence
of a prominent CpG island and a conserved upstream region
to the pCTRP5 gene confirms the presence of a regulatory
region/promoter upstream to pCTRP5.
We have shown that the structure of the pCTRP5 gene is
similar to that found in humans [6,9]. The expression and
localization of the pCTRP5 protein was also found to be
consistent with the hCTRP5 expression in different cell lines,
such as Cos-7 and ARPE-19 cells, indicating that these genes
are highly similar not only in their structure but also in their
function. These findings indicate that a pig model of LAZs
and L-ORD is likely to mimic the human disease. The pig rod-
to-cone  ratio  is  around  8:1  for  the  total  retina  [17,29],
compared to roughly 36:1 in the mouse retina [30]. The pig
will thus be an excellent model for the human disease because
it has a cone-rich retina and a macula-like region, the area
centralis [16]. The pig has been used extensively as a model
of retinitis pigmentosa [31] and is likely to serve as a useful
model of LAZs and L-ORD.
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